Nerve growth factor attenuates oxidant-induced β-amyloid neurotoxicity in sporadic Alzheimer's disease cybrids

被引:25
|
作者
Onyango, Isaac G. [1 ,2 ]
Ahn, Jin-Young [3 ]
Tuttle, Jeremy B. [4 ]
Bennett, James P., Jr. [5 ]
Swerdlow, Russell H. [1 ,2 ]
机构
[1] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA
[2] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA
[3] Seoul Med Ctr, Dept Neurol, Seoul, South Korea
[4] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA
[5] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA
基金
美国国家卫生研究院;
关键词
beta-amyloid; Alzheimer's disease; trans-mitochondrial cybrids; nerve growth factor; oxidative stress; stress-activated protein kinases; ACTIVATED PROTEIN-KINASE; ISCHEMIC BRAIN-INJURY; OXIDATIVE STRESS; SIGNALING PATHWAYS; GENE-EXPRESSION; KAPPA-B; PHOSPHATIDYLINOSITOL; 3-KINASE; MITOCHONDRIAL DYSFUNCTION; TYROSINE PHOSPHORYLATION; NEUROTROPHIC FACTORS;
D O I
10.1111/j.1471-4159.2010.06871.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although mitochondrial dysfunction has been linked to Alzheimer's disease (AD), it is not fully understood how this dysfunction may induce neuronal death. In this study, we show that transmitochondrial hybrid cells (cybrids) expressing mitochondrial genes from patients with sporadic AD (SAD) have substantial alterations in basal upstream tyrosine kinase signaling and downstream serine-threonine kinase signaling that are mediated by intracellular free radicals. This is associated with reduced tropomyocin receptor kinase (TrkA) and p75 neurotrophin receptor receptor expression that profoundly alters nerve growth factor signaling, increases generation of A beta and decreases viability. Many of these observed effects in SAD cybrids would be predicted to increase risk of premature neuronal death and reduce resistance to stressors and add further support for the pathogenic role of mtDNA expression in the pathogenesis of SAD.
引用
收藏
页码:1605 / 1618
页数:14
相关论文
共 50 条
  • [1] Amyloid β-Induced Nerve Growth Factor Dysmetabolism in Alzheimer Disease
    Bruno, Martin A.
    Leon, Wanda C.
    Fragoso, Gabriela
    Mushynski, Walter E.
    Almazan, Guillermina
    Cuello, A. Claudio
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2009, 68 (08) : 857 - 869
  • [2] Oxidant-induced Changes in Mitochondria and Calcium Dynamics in the Pathophysiology of Alzheimer's Disease
    Gibson, Gary E.
    Karuppagounder, Saravanan S.
    Shi, Qingli
    MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS, 2008, 1147 : 221 - 232
  • [3] Endogenous oxidative stress in sporadic Alzheimer's disease neuronal cybrids reduces viability by increasing apoptosis through pro-death signaling pathways and is mimicked by oxidant exposure of control cybrids
    Onyango, IG
    Bennett, JP
    Tuttle, JB
    NEUROBIOLOGY OF DISEASE, 2005, 19 (1-2) : 312 - 322
  • [4] Oestrogen and nerve growth factor - neuroprotection and repair in Alzheimer's disease
    Granholm, AC
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (04) : 685 - 694
  • [5] Avicularin Attenuates Memory Impairment in Rats with Amyloid Beta-Induced Alzheimer’s Disease
    Nikita Patil Samant
    Girdhari Lal Gupta
    Neurotoxicity Research, 2022, 40 : 140 - 153
  • [6] Avicularin Attenuates Memory Impairment in Rats with Amyloid Beta-Induced Alzheimer's Disease
    Samant, Nikita Patil
    Gupta, Girdhari Lal
    NEUROTOXICITY RESEARCH, 2022, 40 (01) : 140 - 153
  • [7] Nerve growth factor gene therapy for Alzheimer's disease
    Tuszynski, MH
    Thal, L
    U, HS
    Pay, MM
    Blesch, A
    Conner, J
    Vahlsing, HL
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2002, 19 (1-2) : 207 - 207
  • [8] Nerve growth factor gene therapy for alzheimer’s disease
    Mark H. Tuszynski
    Leon Thal
    Hoi-Sang U
    Mary Margaret Pay
    Armin Blesch
    James Conner
    H. Lee Vahlsing
    Journal of Molecular Neuroscience, 2002, 19 : 207 - 207
  • [9] Endogenous nerve growth factor in patients with Alzheimer's disease
    Serrano-Sánchez, T
    Robinson-Agramonte, MA
    Lorigados-Pedre, L
    Díaz-Armesto, I
    González-Fragela, ME
    Dorta-Contreras, AJ
    REVISTA DE NEUROLOGIA, 2001, 32 (09) : 825 - 828
  • [10] Targeting the nerve growth factor network in Alzheimer's disease
    Sykiotis, Gerasimos P.
    Papavassiliou, Athanasios G.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (03) : 267 - 269